$18.05
0.01[0.06%]
At close: Apr 24
$18.05
0[0.00%]
After Hours: 4:00PM EDT
MorphoSys
(NASDAQ:MOR)MorphoSys Stock (NASDAQ:MOR), Analyst Ratings, Price Targets, Predictions
MorphoSys AG has a consensus price target of $8.06, established from looking at the 21 latest analyst ratings. The last 3 analyst ratings were released from Wells Fargo, Wells Fargo, and Morgan Stanley on March 14, 2024, February 5, 2024, and January 19, 2024. With an average price target of $11.75 between Wells Fargo, Wells Fargo, and Morgan Stanley, there's an implied -34.90% downside for MorphoSys AG from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
Morgan Stanley
JP Morgan
Goldman Sachs
JMP Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for MorphoSys
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/14/2024 | MOR | Buy Now | MorphoSys | $18.05 | 1.11% | Wells Fargo | Derek Archila | $17 → $18.25 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/05/2024 | MOR | Buy Now | MorphoSys | $18.05 | -5.82% | Wells Fargo | Derek Archila | → $17 | Reiterates | Overweight → Overweight | Get Alert |
| 01/19/2024 | MOR | Buy Now | MorphoSys | $18.05 | — | Morgan Stanley | James Quigley | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/16/2024 | MOR | Buy Now | MorphoSys | $18.05 | — | Morgan Stanley | James Quigley | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/15/2023 | MOR | Buy Now | MorphoSys | $18.05 | -5.82% | Wells Fargo | Derek Archila | $10 → $17 | Maintains | Overweight | Get Alert |
| 12/05/2023 | MOR | Buy Now | MorphoSys | $18.05 | -52.91% | JP Morgan | Richard Vosser | $10 → $8.5 | Maintains | Overweight | Get Alert |
| 11/22/2023 | MOR | Buy Now | MorphoSys | $18.05 | -73.68% | Goldman Sachs | Rajan Sharma | $9.25 → $4.75 | Maintains | Neutral | Get Alert |
| 11/21/2023 | MOR | Buy Now | MorphoSys | $18.05 | -5.82% | JMP Securities | Jason Butler | → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 10/13/2023 | MOR | Buy Now | MorphoSys | $18.05 | -49.03% | Morgan Stanley | James Quigley | $3.7 → $9.2 | Upgrade | Underweight → Overweight | Get Alert |
| 09/15/2023 | MOR | Buy Now | MorphoSys | $18.05 | -48.75% | Goldman Sachs | Rajan Sharma | $3.5 → $9.25 | Upgrade | Sell → Neutral | Get Alert |
| 06/22/2023 | MOR | Buy Now | MorphoSys | $18.05 | -16.9% | JMP Securities | Jason Butler | → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/16/2023 | MOR | Buy Now | MorphoSys | $18.05 | -5.82% | Wells Fargo | Derek Archila | → $17 | Initiates | → Overweight | Get Alert |
| 06/16/2023 | MOR | Buy Now | MorphoSys | $18.05 | -44.6% | JP Morgan | Richard Vosser | $3.3 → $10 | Upgrade | Underweight → Overweight | Get Alert |
| 01/03/2023 | MOR | Buy Now | MorphoSys | $18.05 | — | JP Morgan | Richard Vosser | → $2.9 | Downgrade | Neutral → Underweight | Get Alert |
| 11/18/2022 | MOR | Buy Now | MorphoSys | $18.05 | -16.9% | JMP Securities | Jason Butler | $32 → $15 | Maintains | Market Outperform | Get Alert |
| 01/14/2022 | MOR | Buy Now | MorphoSys | $18.05 | — | Morgan Stanley | James Quigley | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/06/2021 | MOR | Buy Now | MorphoSys | $18.05 | — | Deutsche Bank | — | — | Downgrade | Buy → Hold | Get Alert |
| 06/11/2021 | MOR | Buy Now | MorphoSys | $18.05 | 32.96% | JP Morgan | James Gordon | — | Downgrade | Overweight → Neutral | Get Alert |
| 06/03/2021 | MOR | Buy Now | MorphoSys | $18.05 | — | Bryan Garnier | Victor Floc'h | — | Downgrade | Buy → Neutral | Get Alert |
FAQ
What is the target price for MorphoSys (MOR)?
The latest price target for MorphoSys (NASDAQ: MOR) was reported by Wells Fargo on March 14, 2024. The analyst firm set a price target for $18.25 expecting MOR to rise to within 12 months (a possible 1.11% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MorphoSys (MOR)?
The latest analyst rating for MorphoSys (NASDAQ: MOR) was provided by Wells Fargo, and MorphoSys downgraded their equal-weight rating.
When was the last upgrade for MorphoSys (MOR)?
The last upgrade for MorphoSys AG happened on October 13, 2023 when Morgan Stanley raised their price target to $9.2. Morgan Stanley previously had an underweight for MorphoSys AG.
When was the last downgrade for MorphoSys (MOR)?
The last downgrade for MorphoSys AG happened on March 14, 2024 when Wells Fargo changed their price target from $17 to $18.25 for MorphoSys AG.
When is the next analyst rating going to be posted or updated for MorphoSys (MOR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MorphoSys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MorphoSys was filed on March 14, 2024 so you should expect the next rating to be made available sometime around March 14, 2025.
Is the Analyst Rating MorphoSys (MOR) correct?
While ratings are subjective and will change, the latest MorphoSys (MOR) rating was a downgraded with a price target of $17.00 to $18.25. The current price MorphoSys (MOR) is trading at is $18.05, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.